Global X Genomics & Biotechnology ETF (GNOM)

Complete Genomics Inc. (GNOM) was a life sciences company that specialized in DNA sequencing technology and services. The company's services included whole-genome sequencing and analysis for research and clinical applications.

In 2013, BGI-Shenzhen acquired Complete Genomics and the company became a wholly-owned subsidiary of BGI. As a result, GNOM is no longer publicly traded and there is no current market capitalization or stock price information available.

Investing in GNOM is no longer possible, as the company was acquired and is no longer publicly traded. Investors interested in the life sciences industry may consider other publicly traded companies in the sector. However, any investment carries risks, including risks associated with fluctuations in the stock market and the performance of the underlying assets.